CN103202870A - Drug for reducing temperature of human body - Google Patents
Drug for reducing temperature of human body Download PDFInfo
- Publication number
- CN103202870A CN103202870A CN2013101646986A CN201310164698A CN103202870A CN 103202870 A CN103202870 A CN 103202870A CN 2013101646986 A CN2013101646986 A CN 2013101646986A CN 201310164698 A CN201310164698 A CN 201310164698A CN 103202870 A CN103202870 A CN 103202870A
- Authority
- CN
- China
- Prior art keywords
- drug
- human body
- powder
- temperature
- heat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a drug for reducing temperature of a human body. The drug is prepared from the spices by weight ratio of 0.8-3 parts of chrysanthemum powder, 0.8-3.3 parts of common hogfenneI root powder, 0.3-1.5 parts of tuchahoe powder, and 0.5-1 part of potassium chloride powder. The drug is reasonable in drug compatibility and convenient to take, has the effects of sterilizing and detoxifying, removing heat and relieving exterior syndrome, and starts each gland of the human body after being eaten; the secreta is increased; the concentration of potassium and magnesium ions is increased; and the temperature of the human body is reduced. The drug disclosed by the invention is used for treating various heat illnesses, and is matched with a topical patch for dehydration and detumescence disclosed by another invention to externally apply on the focus of infection. The drug has good curative effects on a patient whose auxiliary temperature is higher than 37 DEG C, having heat illnesses such as cough, stomachache, rheumatic joint pains, cervical and lumbar hyperplasia, protrusion of intervertebral disc, hypertension and tumour; and the complete obliteration rate of pathological lesions can be over 80% by treatment of more than 20 patients with the heat illnesses.
Description
Technical field
The invention belongs to combination of Chinese and Western medicine field, is a kind of cooling medicine of nursing one's health human body temperature, reducing human body temperature.
Background technology
The poised state of body, the metabolism of body cell, requiring must be relatively stable as the body fluid of interior environment, and the main component of body fluid is power and water solution matter.In people's whole life process, there are water, electrolyte to discharge and take in when per, thereby body fluid constantly changes, just because neural, endocrine adjusting have just kept balance, if power and water solution matter Deficiency of Intake or lose too much, surpassed the limited compensatory capacity of body, then the capacity of body fluid, distribution, concentration or composition change, and certainly will cause metabolism disorder, severe patient will influence the function of important organ, even threat to life.The dynamic equilibrium of body fluid mainly comprises: water balance, electrolyte balance, osmotic pressure balance and acid-base balance.Electrolyte balance mainly is that sodium ion, potassium ion, calcium ion, magnesium ion, chloride ion and bicarbonate ion keep dynamic equilibrium, more sodium ion has to advance and has more, lack and advance to lack the function of going out, so saying sodium ion relatively need not investigate very much, chloride ion and bicarbonate ion are combined with sodium, potassium ion, so clinical manifestation is not obvious, there are not much meanings.The osmotic pressure balance is relevant with ion populations in dynamic equilibrium, acid-base balance is also relevant with number of ions, so human body produces disease, namely be that human body loses due balance, the most basic reason is potassium ion, calcium ion and magnesium ion disequilibrium, be accumulated to a certain degree, it is uncomfortable that human body is produced, and produces disease.Calcium, the mutual antagonism of magnesium, calcium, the mutual antagonism of potassium.So the essence of disease is potassium, calcium, magnesium ion disequilibrium.Clinical manifestation is red tongue, xerostomia, and fervescence, xerosis cutis, hypohidrosis, dizzy, fidgety, hallucination, tachycardia, the patient of flush symptom generally is the clinical manifestation of potassium deficiency ion, magnesium ion, we claim that for the time being these symptoms are heat symptom-complex.
There are three big mistaken ideas in modern medicine: 1, disease is regardless of cold and heat; 2, medicine is regardless of cold and heat; 3, food is regardless of cold and heat.Thus and thus cure the disease, the probability of healing is little, and to controlling of antiinflammatory susceptibility sense, child and youthful disease are most responsive, and to later chronic disease of middle age, the antibiotic medicine is just insensitive comparatively speaking.When people ill, particularly suffer from pertinacious disease, incurable diseases such as tumor, hypertension, diabetes, rheumatic arthritis, cervical vertebra, hyperosteogeny, vertebral disc endoprosthesis are outstanding, all be potassium ion, calcium ion and magnesium ion disequilibrium, the capital makes the human body axillary temperature depart from 36.9 ℃-37 ℃ of normal equilibrium values, and for the heat symptom-complex patient, temperature all can be higher than 37 ℃ in the body, also just needs a kind of medicine that can reduce human body temperature, by temperature in the conditioning body, reach the effect of cure diseases.
Summary of the invention
The present invention emphasizes organic conception according to Chinese medicine, is particular about dialectical executing and controls.By measure the cold and heat and asthenia and sthenia of human body with the clinical thermometer take temperature, the human body axillary temperature is higher than more than 37 ℃, examines to be heat syndrome.The objective of the invention is to invent a kind of energy killing pathogenic bacteria, human body temperature is induced sweat, is reduced in heat radiation, and human body temperature is restored balance, and recovers the medicine of the reduction human body temperature of nervous function.
The medicine of reduction human body temperature of the present invention is characterized in that being made up of the spice mixing of following weight proportioning: Flos Chrysanthemi powder 0.8-3 weight portions. preceding English white 0.8-3.3 weight portions, Poria powder 0.5-1.5 weight portions, potassium chloride powder 0.5-1 weight portion.
The medicine of reduction human body temperature of the present invention, the spice of its best proportioning is: Flos Chrysanthemi powder 1 weight portion, preceding English white 1.1 weight portions, Poria powder 0.5 weight portion, potassium chloride powder 1 weight portion.
Flos Chrysanthemi in the above-mentioned component: wind and heat dispersing, detoxifcation; Radix Peucedani: wind and heat dispersing, sending down the abnormal ascending QI expectorant; Poria: promoting diuresis to eliminate damp pathogen, invigorating the spleen and regulating the stomach; Potassium chloride: keep body fluid balance, participate in nervous system activity.
The medicine of reduction human body temperature of the present invention has following clinical effectiveness:
1, medicine enters blood circulation through the oral cavity, the energy killing pathogenic bacteria, and heat radiation is induced sweat, and reduces human body temperature, the interior temperature of body is restored balance, thereby recover nervous function;
2, the essence of disease is potassium, calcium, magnesium ion disequilibrium, takes medicine according to body temperature, can replenish the ion that lacks rapidly, rapidly relief of symptoms.
The medicine of reduction human body temperature of the present invention is mainly used in treating the human body axillary temperature and is higher than all kinds of heat syndrome patients more than 37 ℃.Concerted application of drugs of the present invention is reasonable, and instant has the sterilization detoxifcation, the effect that heat radiation is induced sweat is after eating, through the biochemical absorption of human body, biochemical result, be that each body of gland of human body is opened, secretions increase, potassium, magnesium ion concentration raise, body temperature reduces, be used for the conditioning and treating of various heat syndrome diseases, make the people recover 36.9 ℃-37 ℃ of normal axillary temperatures, recover nervous function.
The specific embodiment
The medicine that reduces human body temperature below in conjunction with the present invention of embodiment is described further.
Embodiment 1: Flos Chrysanthemi powder 1g, preceding English white 1.1g, Poria powder 0.5g, potassium chloride powder 1g.
Embodiment 2: Flos Chrysanthemi powder 0.8g, preceding English white 2g, Poria powder 1.1g, potassium chloride powder 0.9g.
Embodiment 3: Flos Chrysanthemi powder 2g, preceding English white 0.8g, Poria powder 1.2g, potassium chloride powder 0.8g.
Embodiment 4: Flos Chrysanthemi powder 2.5g, preceding English white 2.3g, Poria powder 0.5g, potassium chloride powder 0.5g.
Embodiment 5: Flos Chrysanthemi powder 3g, preceding English white 2.8g, Poria powder 1.5g, potassium chloride powder 0.6g.
Embodiment 6: Flos Chrysanthemi powder 1.5g, preceding English white 3.3g, Poria powder 0.8g, potassium chloride powder 0.7g.
The boiled water that boils is put in the mixing of proportioning spice in above-described embodiment, edible the getting final product of taking after mixing it with water, three times on the one, six hours are once, can treat all kinds of heat syndrome patients that axillary temperature is higher than 37 ℃.
With the medicine of reduction human body temperature of the present invention, the dehydration detumescence external application plaster spare external application focus of adapted invention.To cough, stomachache, rheumatic arthritis, neck, hyperosteogeny, vertebra pass dish is outstanding, hypertension, 20 many cases human body axillary temperatures such as tumor are higher than 37 ℃ heat symptom-complex patient treats, and is a course for the treatment of by 4 weeks, and treat continuous 3 courses for the treatment of, reach fully through treatment and to alleviate, be i.e. the reaching more than 80% of focus complete obiteration.
Concrete case
Case 1: Tang, colporrhagia is examined after the menopause, the crossing hyperplasia that has urine examined is the big hemispherical thing of diameter 2cm, matter is hard, there is the big swollen thing of a pencil stub porch partially, and has courageous and upright logistics to go out, and cervix uteri does not normally have courageous and upright logistics and goes out, take a clinical thermometer to put axillary fossa middle 15 minutes, record 37.9 ℃ of body temperature, the medicine of oral reduction human body temperature of the present invention is with dehydration detumescence external application plaster spare external application pudendum place, at the above external application dehydration of pubic symphysis detumescence external application plaster spare one circle, advise the cold and cool group food of its monophagia, body temperature reaches normal 37 ℃ after the week, and the urethral orifice of hypertrophy obviously dwindles, the swollen thing in porch also dwindles, and house is brought back in administration.Take medicine after advising it to survey body temperature, 3 times on the one, take medicine again after surveying body temperature at every turn.Behind the two weeks, swollen thing disappears in the urethral orifice, and loose urethra is young to the 0.7cm diameter, goes up the method treatment continuously, and month loose disappearance of urethral orifice recovers normal.
2, Lee, 46 years old, in November, 2012 flank pain, the difficulty of getting up, the outstanding companion of lumbar vertebra pass dish hypertrophy is made a definite diagnosis in film making, the two cyclomastopathy of B ultrasonic prompting and a plurality of bundle tuberositys, right breast mammary gland capsule reality tuberosity character is to be checked, size 17 * 9mm, take a clinical thermometer to put axillary fossa middle 15 minutes, record 37.5 ℃ of body temperature, the drug balance body temperature of oral reduction human body temperature of the present invention, dehydration detumescence external application plaster spare external application bilateral breast and the lumbar vertebra position of another invention of adapted, and the cold and cool group food of monophagia.After one month, bilateral breast tuberosity disappears, after three months, and the lumbar vertebra foci disappearance.
Claims (2)
1. medicine that reduces human body temperature is characterized in that spice by the following weight proportioning mixes to form: Flos Chrysanthemi powder 0.8-3 weight portions. preceding English white 0.8-3.3 weight portions, Poria powder 0.5-1.5 weight portions, potassium chloride powder 0.5-1 weight portion.
2. the medicine of reduction human body temperature according to claim 1 is characterized in that the spice of best proportioning is: Flos Chrysanthemi powder 1 weight portion, preceding English white 1.1 weight portions, Poria powder 0.5 weight portion, potassium chloride powder 1 weight portion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101646986A CN103202870A (en) | 2013-05-08 | 2013-05-08 | Drug for reducing temperature of human body |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013101646986A CN103202870A (en) | 2013-05-08 | 2013-05-08 | Drug for reducing temperature of human body |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103202870A true CN103202870A (en) | 2013-07-17 |
Family
ID=48750424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2013101646986A Pending CN103202870A (en) | 2013-05-08 | 2013-05-08 | Drug for reducing temperature of human body |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103202870A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1899543A (en) * | 2006-07-10 | 2007-01-24 | 左耀武 | External plaster for treating child fever and preparing method |
CN101766791A (en) * | 2010-04-19 | 2010-07-07 | 泰一和浦(北京)中医药研究院有限公司 | Chinese herbal composite for fever treatment and preparation method thereof |
-
2013
- 2013-05-08 CN CN2013101646986A patent/CN103202870A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1899543A (en) * | 2006-07-10 | 2007-01-24 | 左耀武 | External plaster for treating child fever and preparing method |
CN101766791A (en) * | 2010-04-19 | 2010-07-07 | 泰一和浦(北京)中医药研究院有限公司 | Chinese herbal composite for fever treatment and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
柯新桥: "略论中医退热十五法", 《中国中医急症》 * |
王子骥: "发热期治疗", 《发热期治疗》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100593417C (en) | Chinese traditional medicine for treating gastric cancer and bone cancer | |
CN102688420A (en) | Traditional Chinese medicine decoction for treating psoriasis | |
CN103007175B (en) | Traditional Chinese medicine package for treating infantile diarrhea | |
CN103386100A (en) | Autumn diarrhea paste | |
CN101507736B (en) | Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism | |
CN102198202B (en) | Pills for treating gout | |
CN103202870A (en) | Drug for reducing temperature of human body | |
CN102793870A (en) | Chinese herbal medicine for treating renal calculi | |
CN112263785A (en) | Application of bed body based on light wave therapy in chronic disease aspect | |
CN102755456B (en) | Traditional Chinese medicine formula and capsule for dissolving kidney stone | |
CN103223035B (en) | Medicine for raising body temperature | |
CN104027741B (en) | A kind of oral medication women Chondromalacia of patella Chinese medicine composition | |
CN103830486A (en) | Traditional Chinese medicine for treating globus hysteriocus | |
CN103230547A (en) | Traditional Chinese medicine for treating intractable hiccup | |
CN104740302B (en) | A kind of Chinese medicine composition for treating Qi deficiency blood stasis type lumbar spinal stenosis | |
CN103610988B (en) | A kind of Chinese medicine composition for the treatment of heat disease | |
CN106215070A (en) | A kind of Chinese medicine treating infantile enuresis | |
CN101856425A (en) | Externally applied medicine for alleviating cancer pain and preparation method thereof | |
CN107243038A (en) | A kind of pharmaceutical composition for treating gout | |
CN106822734A (en) | A kind of numbness relieving and pain relieving externally used medicine bag | |
CN101264268B (en) | Proprietary Chinese medicine for treating tumor | |
CN104740620A (en) | Ant pill and application thereof | |
Feng et al. | Moxibustion on Governor Vessel for ankylosing spondylitis due to kidney yang deficiency: a clinical controlled study | |
CN105832885A (en) | Traditional Chinese medicine composition for treating insomnia | |
CN103990029A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130717 |